MyelomaCide

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameMyelomaCide
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedRadiation-emitting products
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomedics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunomedics
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A